Aroa Biosurgery Wins Regulatory Approvals for Wound Care Products

MT Newswires Live2024-10-22

Aroa Biosurgery's (ASX:ARX) secured regulatory approvals to market and sell the Endoform and Myriad Matrix products in Argentina and Endoform in Egypt, according to a Tuesday filing with the Australian bourse.

Endoform was developed for the management of acute and chronic wounds, while Myriad Matrix is used in soft tissue reconstruction and complex wounds.

The soft tissue regeneration firm's cash receipts rose 35% to NZ$19.9 million in the second quarter ended Sept. 30, compared with the previous comparable period, the filing added.

Shares of Aroa Biosurgery rallied almost 12% at market close.

Price (AUD): $0.58, Change: $+0.060, Percent Change: +11.54%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2477774178?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-22 14:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477774178","market":"sg","top_or_hot":-1,"title":"Aroa Biosurgery Wins Regulatory Approvals for Wound Care Products","media":"MT Newswires Live","content":"<html><body><p> Aroa Biosurgery's (ASX:ARX) secured regulatory approvals to market and sell the Endoform and Myriad Matrix products in Argentina and Endoform in Egypt, according to a Tuesday filing with the Australian bourse.</p><p>Endoform was developed for the management of acute and chronic wounds, while Myriad Matrix is used in soft tissue reconstruction and complex wounds.</p><p>The soft tissue regeneration firm's cash receipts rose 35% to NZ$19.9 million in the second quarter ended Sept. 30, compared with the previous comparable period, the filing added.</p><p>Shares of Aroa Biosurgery rallied almost 12% at market close.</p><p>Price (AUD): $0.58, Change: $+0.060, Percent Change: +11.54%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aroa Biosurgery Wins Regulatory Approvals for Wound Care Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAroa Biosurgery Wins Regulatory Approvals for Wound Care Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-22 14:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Aroa Biosurgery's (ASX:ARX) secured regulatory approvals to market and sell the Endoform and Myriad Matrix products in Argentina and Endoform in Egypt, according to a Tuesday filing with the ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AUD","symbol_name":"Audacy Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2477774178","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477774178","pubTimestamp":1729579583,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Aroa Biosurgery's  secured regulatory approvals to market and sell the Endoform and Myriad Matrix products in Argentina and Endoform in Egypt, according to a Tuesday filing with the Australian bourse.Endoform was developed for the management of acute and chronic wounds, while Myriad Matrix is used in soft tissue reconstruction and complex wounds.The soft tissue regeneration firm's cash receipts rose 35% to NZ$19.9 million in the second quarter ended Sept. 30, compared with the previous comparable period, the filing added.Shares of Aroa Biosurgery rallied almost 12% at market close.Price : $0.58, Change: $+0.060, Percent Change: +11.54%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AUD":"Audacy Inc.","BK7067":"生物科技","BK4125":"广播","ARX.AU":"AROA BIOSURGERY LTD"},"translate_title":"Aroa Biosurgery伤口护理产品获得监管部门批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AUD":1,"ARX.AU":0.9},"content_text":"Aroa Biosurgery's (ASX:ARX) secured regulatory approvals to market and sell the Endoform and Myriad Matrix products in Argentina and Endoform in Egypt, according to a Tuesday filing with the Australian bourse.Endoform was developed for the management of acute and chronic wounds, while Myriad Matrix is used in soft tissue reconstruction and complex wounds.The soft tissue regeneration firm's cash receipts rose 35% to NZ$19.9 million in the second quarter ended Sept. 30, compared with the previous comparable period, the filing added.Shares of Aroa Biosurgery rallied almost 12% at market close.Price (AUD): $0.58, Change: $+0.060, Percent Change: +11.54%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477774178"}